Page 189 - MEMORIA ANUAL 2021
P. 189

   MEMORIA ANUAL 2021 SOCIEDAD ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
GELLC
FUNDACIÓN ESPAÑOLA DE HEMATOLOGÍA Y HEMOTERAPIA
  • Biological significance of monoallelic and biallelic BIRC3 loss in del(11q) chronic lym- phocytic leukemia progression.
Blood Cancer J. 2021 Jul 9;11(7):127. doi: 10.1038/s41408-021-00520-5.
Quijada-Álamo M, Hernández-Sánchez M, Rodríguez-Vicente AE, Pérez-Carretero C, Rodríguez-Sánchez A, Martín-Izquierdo M, Alonso-Pérez V, García-Tuñón I, Bastida JM, Vidal-Manceñido MJ, Galende J, Aguilar C, Queizán JA, González-Gascón Y Marín I, Her- nández-Rivas JÁ, Benito R, Ordóñez JL, Hernández-Rivas JM .
• COVID-19 in patients with CLL: improved survival outcomes and update on manage- ment strategies.
Blood. 2021 Nov 4;138(18):1768-73. doi: 10.1182/blood.2021011841.
Roeker LE, Eyre TA, Thompson MC, Lamanna N, Coltoff AR, Davids MS, Baker PO, Leslie L, Rogers KA, Allan JN, Córdoba R, López-García A, Antic D, Pagel JM, Martínez- Calle N, García-Marco JA, Hernández-Rivas JÁ, Miras F, Coombs CC, Österborg A, Hansson L, Seddon AN, López Jiménez J, Wilson MR, El-Sharkawi D, Wojenski D, Ma S, Munir T, Valenciano S, Seymour E, Barr PM, Pu J, Patten PEM, Perini GF, Huntington SF, Parry H, Sundaram S, Skarbnik A, Kamdar M, Jacobs R, Walter H, Walewska R, Broom A, Lebowitz S, Isaac KM, Portell CA, Ahn IE, Ujjani CS, Shadman M, Skånland SS, Chong EA, Mato AR .
• Severe infections in patients with lymphoproliferative diseases treated with new targeted drugs: A multicentric real-world study.
Cancer Med. 2021 Nov;10(21):7629-40. doi: 10.1002/cam4.4293.
Stefania Infante M, Fernández-Cruz A, Núñez L, Carpio C, Jiménez-Ubieto A, López-Ji- ménez J, Vásquez L, Del Campo R, Romero S, Alonso C, Morillo D, Prat M, Luis Plana J, Villafuerte P, Bastidas G, Bocanegra A, Serna Á, De Nicolás R, Marquet J, Mas-Ochoa C, Córdoba R, García-Suárez J, Comai A, Martín X, Bastos-Oreiro M, Seri C, Navarro-Matilla B, López-Guillermo A, Martínez-López J, Ángel Hernández-Rivas J, Ruiz-Camps I, Grande C; Grupo Español de Linfomas y Trasplante Autólogo de Medula Ósea (GELTAMO) .
• Restoration of the immune function as a complementary strategy to treat chronic lymphocytic leukemia effectively.
J Exp Clin Cancer Res. 2021 Oct 15;40(1):321. doi: 10.1186/s13046-021-02115-1.
Moreno C, Muñoz C, Terol MJ, Hernández-Rivas JÁ, Villanueva M .
• Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibru- tinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study).
Clin Lymphoma Myeloma Leuk. 2021 Dec;21(12):e985-e999. doi: 10.1016/j. clml.2021.07.022.
 189
 















































































   187   188   189   190   191